News, Commercial Litigation, Defective Products

Aveeno Lawsuit: Baby Wash False Advertising Claims

Seeger Weiss LLP is investigating claims that Aveeno falsely advertised that their baby wash products were natural.

Parents will do whatever it takes to ensure that their babies are healthy and safe.  That’s why the market for “natural” products – free of carcinogens and synthetic chemicals—is growing.

Aveeno, a subsidiary of consumer goods giant, Johnson and Johnson, prides itself in manufacturing natural skin and hair care products.  Particularly, the Aveeno Baby Wash and the Aveeno Baby Calming Comfort Bath are advertised as containing a “Natural Oat Formula.”

Seeger Weiss LLP, however, is investigating claims that Aveeno falsely advertised that their baby wash products were natural.  It is alleged that these products actually contain potentially dangerous unnatural ingredients such as, Quaternium 15, a preservative that works by slowly releasing formaldehyde, a known human carcinogen used for embalming and as a disinfectant; glycol distearate, which acts as a skin conditioning agent, and PEG 15 distearate, which is derived from stearic acid and is used as a surfactant.

By relying on Aveeno’s alleged false misrepresentations, consumers paid more for these “natural” products.  More importantly, it is alleged that parents were deceived into believing that Aveeno’s products would be entirely natural and safer to use on their babies.

As we further our investigation, we ask anyone who has purchased Aveeno Baby Wash or Aveeno Baby Calming Comfort Bath to contact us if you purchased these products believing that they were all natural.  All initial attorney consultations are free of charge.

Seeger Weiss LLP is a highly experienced class action law firm.  We strive to provide the highest quality of service to our clients, treating each case with careful attention.  Seeger Weiss has offices in New York, New Jersey, and Pennsylvania.


Since its establishment in 1999, Seeger Weiss has led some of the most complex and high-profile litigations in the U.S.